SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-037025
Filing Date
2019-10-16
Accepted
2019-10-16 16:23:38
Documents
19
Period of Report
2019-10-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K_LEASE AGREEMENT AND EXPANSION AGREEMENT reta-8k_20191015.htm   iXBRL 8-K 43302
2 EX-10.1 reta-ex101_45.htm EX-10.1 1338038
3 EX-10.2 reta-ex102_111.htm EX-10.2 140979
4 GRAPHIC gtzqxrwb5wsb000004.jpg GRAPHIC 62694
5 GRAPHIC gtzqxrwb5wsb000003.jpg GRAPHIC 54251
6 GRAPHIC gtzqxrwb5wsb000001.jpg GRAPHIC 41481
7 GRAPHIC gtzqxrwb5wsb000005.jpg GRAPHIC 73442
8 GRAPHIC gtzqxrwb5wsb000002.jpg GRAPHIC 55554
  Complete submission text file 0001564590-19-037025.txt   2266154

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA reta-20191015.xsd EX-101.SCH 5964
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20191015_lab.xml EX-101.LAB 20242
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20191015_pre.xml EX-101.PRE 12081
16 EXTRACTED XBRL INSTANCE DOCUMENT reta-8k_20191015_htm.xml XML 3690
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 191152988
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences